← All trials
NCT00696514
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2008
- Primary completion
- Mar 1, 2013
- Completion date
- Mar 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 3000
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Wageningen UniversityLead sponsor
- Wageningen UniversityOverall official - principal investigator
- ZonMw: The Netherlands Organisation for Health Research and DevelopmentCollaborator
- NZO: Dutch Dairy AssociationCollaborator
- Free University of AmsterdamCollaborator
- Erasmus University RotterdamCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.